PPD skin test - Results
Purified protein derivative standard; TB skin test; Tuberculin skin test; Mantoux test
A negative reaction (no induration) or a size of hard swelling that falls below the cutoff for each risk group usually means that you have not been infected with the bacteria that cause TB. There are different cutoffs for children, people with HIV, and other risk groups.
This is not a perfect test. Up to 20% of people infected with the bacteria that cause TB may not have a reaction on the PPD skin test. In addition, certain conditions that impair the immune system (cancer, recent chemotherapy, late-stage AIDS) may cause a false-negative test result.
What abnormal results mean:
The test results depend on the size of the skin reaction and the person being tested.
A small reaction (5 mm of firm swelling at the site) is considered to be positive in people:
- Who have HIV
- Who have received an organ transplant
- Who have a suppressed immune system or are taking steroid therapy (about 15 mg of prednisone per day for 1 month)
- Who have been in close contact with a person who has active TB
- Who have changes on a chest x-ray that look like past TB
Larger reactions (greater than or equal to 10 mm) are considered positive in:
- People with a known negative test in the past 2 years
- People with diabetes, kidney failure, or other conditions that increase their chance of getting active TB
- Health care workers
- Injection drug users
- Immigrants who have moved from a country with a high TB rate in the past 5 years
- Children under age 4
- Infants, children, or adolescents who are exposed to high-risk adults
- Students and employees of certain group living settings, such as prisons, nursing homes, and homeless shelters
In people with no known risks for TB, 15 mm or more of firm swelling at the site indicates a positive reaction.
- Reviewed last on: 12/7/2010
- David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and Jatin M. Vyas, PhD, MD, Instructor in Medicine, Harvard Medical School, Assistant in Medicine, Division of Infectious Disease, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
Fitzgerald DW, Sterling TR, Haas DW. Mycobacterium tuberculosis. In: Mandell GL, Bennett JE, Dolan R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 7th ed. Orlando, FL: Saunders Elsevier;2009:chap 250.
Iseman MD. Tuberculosis. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 345.
The information provided herein should not be used during any medical emergency or for the
diagnosis or treatment of any medical condition. A licensed medical professional should be
consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all
medical emergencies. Links to other sites are provided for information only -- they do not
constitute endorsements of those other sites. © 1997-
A.D.A.M., Inc. Any duplication or distribution of the information contained herein is
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885